No matter who leads Intel, Bob Swan, Pat Gelsinger, or Li-Bu Tan, they all face the same fundamental challenge: under the IDM business model, Intel’s Capex and R&D spending are allocated to both manufacturing (foundry) and product division. The money are spread too far, too thin, and across too many directions as the company tries to compete in too many markets. Without changing the IDM model itself, any Intel CEO can only delay or disguise a structural problem that eventually becomes a crisis.
On the manufacturing side, whether serving internal or external customers, Intel Foundry cannot compete or move quickly enough with the level of Capex and R&D it has. It is outgunned by TSMC while stretching its own capital to an unsustainable level.
On the product and design side, Intel struggles to keep up with fabless, Capex light competitors such as Nvidia, AMD, Broadcom, Qualcomm, MediaTek, Apple, Microsoft, Google, and Amazon, all of whom can develop new products faster and capture emerging opportunities more effectively.
Under the IDM business model, Intel’s revival or even its survival depends on increasing both Capex and R&D spending. But Intel has very little room left to push those investments further.
If we measure Intel’s R&D effectiveness by comparing the current year’s net profit to the previous year’s R&D spending, it becomes obvious that Intel cannot continue on its current trajectory.
Comparison of Capex Spending:
View attachment 4052
View attachment 4053
View attachment 4054
Nvidia Fiscal Year Ended in January each year.
Comparison of R&D Spending:
View attachment 4051
View attachment 4049
View attachment 4050
Nvidia Fiscal Year Ended in January each year.